Trial Profile
A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2019
Price :
$35
*
At a glance
- Drugs Meclofenamic acid (Primary) ; Pentosan polysulfate (Primary)
- Indications Bipolar I disorders; Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 25 Mar 2019 Status changed from recruiting to completed.
- 03 Nov 2017 Planned End Date changed from 1 Aug 2017 to 4 Nov 2017.
- 13 Oct 2016 New trial record